Cctu

This study tests whether adding a stronger chemotherapy regimen (FOLFOXIRI) to standard chemoradiation before surgery can improve outcomes for people with high-risk locally advanced rectal cancer. About 72 participants will be randomly assigned to receive either standard treatmen…

This study tests the drug pembrolizumab in 30 people with advanced liver cancer caused by hepatitis B. The goal is to see if the drug can shrink tumors and improve survival, while also studying how the immune system changes during treatment. Participants must have stable hepatiti…

This study compares two types of radiation therapy for men with high-risk prostate cancer that has not spread. One group gets standard radiation (38 sessions over 8 weeks) and the other gets a shorter course (5 sessions over 5 weeks). Both groups also receive hormone therapy. The…